Apieron, Inc.
Apieron is developing a noninvasive monitor to measure exhaled nitric oxide for managing inflammation and controlling the underlying disease of asthma. Asthma is a chronic inflammatory disease of the airways in the lungs affecting more than 18 million people in the U.S. Controlling inflammation is the central focus for managing the underlying disease of asthma and regular use of anti-inflammatory medications is now the mainstay for treatment of symptoms. Nitric oxide has been shown to be a marker for inflammation and provides a means for monitoring the patient’s response to anti-inflammatory therapy. Clinical research strongly suggests that monitoring exhaled NO on a regular basis could significantly improve disease management.
www.apieron.com
Transoma Medical
Transoma Medical is a leading provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and is the gold standard for monitoring and collecting physiological data in biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.
www.transomamedical.comMeet Specializing Partners
Brent Ahrens
Stephen Bloch
Wende Hutton
Mickey Kim
Seth Rudnick
News
Downloads
Canaan Brochure [pdf, 1.2MB]
Healthcare Factsheet [pdf, 1.16MB]
© 2008 Canaan Partners